Medication overuse headache;Medicinoverforbrugshovedpine

Ugeskrift for Laeger

Volumn 168, Issue 10, 2006, Pages 1015-1019

  Ashina, Sait ^a   Zeeberg, Peter ^a   Jensen, Rigmor Højland ^a   Ashina, Messoud ^a  

^a GLOSTRUP UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ANALGESIC AGENT; ERGOT ALKALOID; SUMATRIPTAN; TRIPTAN DERIVATIVE; SEROTONIN AGONIST; VASOCONSTRICTOR AGENT;

DISEASE SEVERITY; DRUG INDUCED HEADACHE; DRUG USE; DRUG WITHDRAWAL; HEADACHE; HUMAN; MIGRAINE; PATHOPHYSIOLOGY; PATIENT EDUCATION; PRIMARY MEDICAL CARE; PROGNOSIS; REVIEW; TENSION HEADACHE; CHEMICALLY INDUCED DISORDER; DIFFERENTIAL DIAGNOSIS; DRUG COMBINATION; HEADACHE AND FACIAL PAIN; SELF MEDICATION;

ANALGESICS; DIAGNOSIS, DIFFERENTIAL; DRUG COMBINATIONS; HEADACHE DISORDERS; HUMANS; PROGNOSIS; SELF MEDICATION; SEROTONIN AGONISTS; VASOCONSTRICTOR AGENTS;

EID: 33644923786     PISSN: 00415782     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (40)

1. Zwart JA, Dyb G, Hagen K et al. Analgesic overuse among subjects with headache, neck, and low-back pain. Neurology 2004;62:1540-4.
2. Bahra A, Walsh M, Menon S et al. Does chronic daily headache arise de novo in association with regular use of analgesics? Headache 2003;43:179-90.
3. Guitera V, Munoz P, Castillo J et al. Quality of life in chronic daily headache: a study in a general population. Neurology 2002;58:1062-5.
4. Gaist D. Use and overuse of sumatriptan. Cephalalgia 1999;19:735-61.
5. Rapoport A, Stang P, Gutterman DL et al. Analgesic rebound headache in clinical practice: data from a physician survey. Headache 1996;36:14-9.
6. Wang SJ, Fuh JL, Lu SR et al. Chronic daily headache in Chinese elderly: prevalence, risk factors, and biannual follow-up. Neurology 2000;54:314-9.
7. Lampl C, Buzath A, Yazdi K et al. Ergot and triptan overuse in Austria - an evaluation of clinical data and cost. Cephalalgia 2002;22:807-11.
8. Peters GA, Horton BT. Headache: with special reference to the excessive use of ergotamine preparations and withdrawal effects. Mayo Clin Proc 1951;26:153-61.
9. Headache Classification Committee of the International Headache Society. Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia 1988;8(suppl 7):1-96.
10. Gaist D, Hallas J, Sindrup SH et al. Is overuse of sumatriptan a problem? Eur J Clin Pharmacol 1996;50:161-5.
11. Evers S, Gralow I, Bauer B et al. Sumatriptan and ergotamine overuse and drug-induced headache: a clinicoepidemiologic study. Clin Neuropharmacol 1999;22:201-6.
12. Limmroth V, Kazarawa Z, Fritsche G et al. Headache after frequent use of serotonin agonists zolmitriptan and naratriptan. Lancet 1999;353:78.
13. Headache Classification Subcommittee of the International Headache Society. The International Classification of Headache Disorders: 2nd edition. Cephalalgia 2004;24(suppl 1):9-160.
14. Diener HC, Dahlöf C. Headache associated with chronic use of substances. I: Olesen J, Tfelt-Hansen P, Welch KM, eds. The Headaches. 2nd ed. Philadelphia: Lippincott Williams & Wilkins, 2000: 871-8.
15. Rasmussen BK, Jensen R, Schroll M et al. Epidemiology of headache in a general population - a prevalence study. J Clin Epidemiol 1991;44:1147-57.
16. Limmroth V, Katsarava Z, Fritsche G et al.. Features of medication overuse headache following overuse of different acute headache drugs. Neurology 2002;59:1011-4.
17. Russell MB, Rasmussen BK, Brennum J et al. Presentation of a new instrument: the diagnostic headache diary. Cephalalgia 1992;12:369-74.
18. Robinson RG. Pain relief for headaches. Can Fam Physician 1993;39:867-2.
19. Granella F, Farina S, Malferrari G et al. Drug abuse in chronic headache: a clinico-epidemiologic study. Cephalalgia 1987;7:15-9.
20. Castillo J, Munoz P, Guitera V et al. Epidemiology of chronic daily headache in the general population. Headache 1999;39:190-6.
21. Evers S, Suhr B, Bauer B et al. A retrospective long-term analysis of the epidemiology and features of drug-induced headache. J Neurol 1999;246:802-9.
22. Silberstein SD, Schulman EA, Hopkins MM. Repetitive intravenous DHE in the treatment of refractory headache. Headache 1990;30:334-9.
23. Walker J, Parisi S, Olive D. Analgesic rebound headache: experience in a community hospital. South Med J 1993;86:1202-5.
24. Zeeberg P, Olesen J, Jensen R. Efficacy of multidisciplinary treatment in a tertiary referral Headache Center. Cephalalgia 2005;25:1159-67.
25. Centonze V, Bassi A, Causarano V et al. Sumatriptan overuse in episodic cluster headache: lack of adverse events, rebound syndromes, drug dependence and tachyphylaxis. Funct Neurol 2000;15:167-70.
26. Lance F, Parkes C, Wilkinson M. Does analgesic abuse cause headaches de novo? Headache 1988;28:61-2.
27. Silberstein SD, Lipton RB. Chronic daily headache, including transformed migraine, chronic tension-type headache, and medication overuse. I: Silberstein SD, Lipton RB, Dalessio DJ, eds. Wolff's headache and other head pain. 7th ed. New York: Oxford University Press, 2001:247-82.
28. Bendtsen L. Sensitization: its role in primary headache. Curr Opin Investig Drugs 2002;3:449-53.
29. Katsarava Z, Fritsche G, Muessig M et al. Clinical features of withdrawal headache following overuse of triptans and other headache drugs. Neurology 2001;57:1694-8.
30. Hagen K, Vatten L, Stovner LJ et al. Low socio-economic status is associated with increased risk of frequent headache: a prospective study of 22718 adults in Norway. Cephalalgia 2002;22:672-9.
31. Atasoy HT, Unal AE, Atasoy N et al. Low income and education levels may cause medication overuse and chronicity in migraine patients. Headache 2005;45:25-31.
32. Diener HC, Limmroth V. Medication-overuse headache: a worldwide problem. Lancet Neurol 2004;3:475-83.
33. Baumgartner C, Wessely P, Bingol C et al. Longterm prognosis of analgesic withdrawal in patients with drug-induced headaches. Headache 1989;29:510-4.
34. Diener HC, Dichgans J, Scholz E et al. Analgesic-induced chronic headache: long-term results of withdrawal therapy. J Neurol 1989;236:9-14.
35. Tfelt-Hansen P, Krabbe A. Ergotamine abuse. Cephalalgia 1981;1:29-32.
36. Schnider P, Aull S, Baumgartner C et al. Long-term outcome of patients with headache and drug abuse after inpatient withdrawal: five-year follow-up. Cephalalgia 1996;16:481-5.
37. Tribl GG, Schnider P, Wober C et al. Are there predictive factors for long-term outcome after withdrawal in drug-induced chronic daily headache? Cephalalgia 2001;21:691-6.
38. Fritsche G, Eberl A, Katsarava Z et al. Drug-induced headache: long-term follow-up of withdrawal therapy and persistence of drug misuse. Eur Neurol 2001;45:229-35.
39. Katsarava Z, Limmroth V, Finke M et al. Rates and predictors for relapse in medication overuse headache: a 1-year prospective study. Neurology 2003;60:1682-3.
40. Katsarava Z, Muessig M, Dzagnidze A et al. Medication overuse headache: rates and predictors for relapse in a 4-year prospective study. Cephalalgia 2005;25:12-5.